Evidence map›Paper›PMID 17109908›Full record

ArticleToxicology and applied pharmacology2006

TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone.

Howard G Shertzer, Mary Beth Genter, Dongxiao Shen, Daniel W Nebert, Ying Chen, Timothy P Dalton

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Environmental health perspectives · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Mitochondria as a target of environmental toxicants.Toxicological sciences : an official journal of the Society of Toxicology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Howard G ShertzerDepartment of Environmental Health and Center for Environmental Genetics, University of Cincinnati Medical Center, P.O. Box 670056 Cincinnati, OH 45267-0056, USA. shertzhg@ucmail.uc.edu
Mary Beth Genter
Dongxiao Shen
Daniel W Nebert
Ying Chen
Timothy P Dalton
University of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
CYPIAI GENE AND ENVIRONMENTAL ToxicityR01ES008147 · NIEHS · UNIVERSITY OF CINCINNATI · PI NEBERT, DANIEL W. · 1996 to 2005
$2.5M
Glutathione in Environmental Toxicity and DiseaseR01ES012463 · NIEHS · UNIVERSITY OF CINCINNATI · PI SHERTZER, HOWARD · 2003 to 2007
$1.6M
RECEPTOR MEDIATED OXIDATIVE STRESSR01ES010133 · NIEHS · UNIVERSITY OF CINCINNATI · PI SHERTZER, HOWARD · 2000 to 2003
$888k
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P30 ES006096-06A19011NIEHS NIH HHS P30 ES06096NIEHS NIH HHS R01 ES008147NIEHS NIH HHS R01 ES010133NIEHS NIH HHS R01 ES010133-01A1NIEHS NIH HHS R01 ES010133-02NIEHS NIH HHS R01 ES010133-03NIEHS NIH HHS R01 ES010133-04NIEHS NIH HHS R01 ES012463NIEHS NIH HHS R01 ES08147NIEHS NIH HHS R01 ES10133NIEHS NIH HHS R01 ES12463
6 · The paper itself

Abstract

Mitochondria generate ATP and participate in signal transduction and cellular pathology and/or cell death. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) decreases hepatic ATP levels and generates mitochondrial oxidative DNA damage, which is exacerbated by increasing mitochondrial glutathione redox state and by inner membrane hyperpolarization. This study identifies mitochondrial targets of TCDD that initiate and sustain reactive oxygen production and decreased ATP levels. One week after treating mice with TCDD, liver ubiquinone (Q) levels were significantly decreased, while rates of succinoxidase and Q-cytochrome c oxidoreductase activities were increased. However, the expected increase in Q reduction state following TCDD treatment did not occur; instead, Q was more oxidized. These results could be explained by an ATP synthase defect, a premise supported by the unusual finding that TCDD lowers ATP/O ratios without concomitant changes in respiratory control ratios. Such results suggest either a futile cycle in ATP synthesis, or hydrolysis of newly synthesized ATP prior to release. The TCDD-mediated decrease in Q, concomitant with an increase in respiration, increases complex 3 redox cycling. This acts in concert with glutathione to increase membrane potential and reactive oxygen production. The proposed defect in ATP synthase explains both the greater respiratory rates and the lower tissue ATP levels.

Indexed as

Adenosine TriphosphateAnimalsElectron Transport Complex IIIEnvironmental PollutantsLiverMaleMiceMice, Inbred C57BLMitochondria, LiverOxidoreductasesPolychlorinated DibenzodioxinsProton-Translocating ATPasesReactive Oxygen SpeciesUbiquinoneAdenosine TriphosphateElectron Transport Complex IIIEnvironmental PollutantsOxidoreductasesPolychlorinated DibenzodioxinsProton-Translocating ATPasesReactive Oxygen Speciessuccinate oxidaseUbiquinone

Identifiers

PMID17109908
PMCPMC1783833
OpenAlexW2137005762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.